Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06189820 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases

Study acronym: FAPIPET
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
To evaluate the effect of an anti-fibrotic treatment initiation on the fibrotic activity as assessed by FAPI PET/CT.
Trial Details
NCT Number NCT06189820
Lead Sponsor Erasme University Hospital
Conditions
(from sponsor)		 Pulmonary Fibrosis, Lung Fibrosis, Idiopathic Pulmonary Fibrosis, FAP
Related terms Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov